Health Care·Life Sciences Tools & Services·$9.4B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.24 | N/A | +48.94% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.24 | N/A | +48.94% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a cautious optimism about the company's direction. They acknowledged current market challenges while emphasizing their commitment to improving operations.
Management highlighted improvements in operational efficiency.
They noted ongoing challenges in the market but expressed confidence in future strategies.
Tempus AI Inc Class A reported a narrower-than-expected loss per share, which was a positive surprise for investors. However, the stock fell by 3.48% following the earnings report, likely due to the lack of revenue information and guidance. Investors may be concerned about the company's future performance without clear direction.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
PALANTIR TECHNOLOGIE Class A
May 5, 2025